Pharmacological properties
Docsilamin (n, n-dimethyl-2 [1-phenyl-1 (piridinit) etoks] ethanolamine) — somnolent means of a class of ethanolamines from group of blockers of histamine h1-receptors, renders sedative and m-holinoblokiruyushchee action. reduces backfilling time, increases duration and sleep quality, at the same time does not change phase structure of a dream.
succinate is well soaked up by Docsilamin'sfrom a digestive tract, biotransformation is carried out in a liver. The main part of a docsilamin (about 60%) is removed in not changed view with urine, a part — with a stake.
Indication
Insomnia and other sleep disorders.
Use
byis Appointed only to adults and teenagers 15 years, on 1 tablet in 15–30 min. prior to a dream are more senior. depending on individual reaction of the patient the dose of medicine can be lowered up to 1/2 tablets or to raise to 2 tablets.
Contraindication
Glaucoma, violations from an urethra and a prostate, the feeding period a breast (at administration of medicament it is necessary to stop breastfeeding), age up to 15 years, hypersensitivity to drug.
Side effects
Are connected bywith holinoblokiruyushchy effect of medicine — feeling of dryness in a mouth, accommodation violation, a lock, the complicated urination (especially at patients with tendency to these phenomena).
Special instructions
applyWith care at diseases of lungs. it is not necessary to appoint to drivers of transport (decrease in attention, drowsiness).
byInteraction
At simultaneous application with barbiturates, benzodiazepines, a clonidine, opioid analgetics, neuroleptics, tranquilizers observes strengthening of overwhelming action on central nervous system. at a concomitant use of a sondoks with atropine or other blockers of m-holinoretseptorov the risk of emergence of anticholinergic by-effects increases: dryness in a mouth, the complicated urination. alcohol strengthens sedative action of a docsilamin that can make unsafe driving of vehicles and work with potentially dangerous mechanisms.
Overdose
Is possibleonly at reception in very high doses. symptoms: mydriasis, dermahemia of the person, hyperthermia, excitement, lacks of coordination, shiver, athetotic movements, spasms. in the absence of treatment the coma which is followed by collapse can develop.
symptomatic treatment. According to indications use anticonvulsant medicaments and carry out IVL.
Storage conditions
B the dry, protected from light place.
Characteristics | |
Active ingredients | Docsilamin |
Amount of active ingredient | 15 mg |
Applicant | Red star |
Code of automatic telephone exchange | N05CM Other hypnotic drugs and sedatives |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Generic-generic |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | blister |
Producer | Z_RKA THE STALEMATE H_MZAVOD IS RED |
Quantity in packing | 30 tablets (3 blisters on 10 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Sondoks |
Sondoks tab. of 0.015 g No. 30
- Product Code: 178165
- In Stock
- Ready to ship
-
$20.33